5-androstene 3.beta., 17.beta. diol for treatment

Details 5-androstene 3.beta., 17.beta. diol for treatment 5-androstene 3.beta., 17.beta. diol for treatment

1995-10-23

1997-06-24

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514171, 514179, A61K 3156

Patent

active

056417683

ABSTRACT:
The present invention provides a composition comprising a dosage from containing 0.2 to 30 mg of 5-androstene 3 .beta.,17.beta. diol in a pharmaceutical carrier, and a method of preventing cells from adhering to one another by exposing the cells to an adhering-inhibiting amount of 5-androstene 3.beta.,17.beta. diol or 5-androstene 3.beta.,7.beta.,17.beta. triol.

REFERENCES:
patent: 2170124 (1939-08-01), Butenandt et al.
patent: 2521586 (1950-09-01), Levy et al.
patent: 2845381 (1958-07-01), Tindall
patent: 4542129 (1985-09-01), Orentreich
patent: 4898694 (1990-02-01), Schwartz
patent: 4978532 (1990-12-01), El-Rashidy
patent: 5077284 (1991-12-01), Loria et al.
patent: 5206008 (1993-04-01), Loria
patent: 5277907 (1994-01-01), Loria
patent: 5387583 (1995-02-01), Loria
patent: 5391776 (1995-02-01), Ueno et al.
patent: 5461042 (1995-10-01), Loria
Windholz et al., The Merck Index, Tenth Ed. (1983) p. 93, abstract No. 662.

Affiliated with

Also associated with

Rating

5-androstene 3.beta., 17.beta. diol for treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-androstene 3.beta., 17.beta. diol for treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-androstene 3.beta., 17.beta. diol for treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-149266